TFAM and cancer: Defective mtDNA repair pathways or downregulated mtDNA repair-associated proteins, such as mitochondrial transcription factor A (mtTFA) and POLγ, together with administered DDR inhibitors, can result in higher sensitivity of cancer cells to radio- or chemotherapy [153,154].